EUVIMEDEUVIMED entdecken
Crossref

Thirty-two-year trends in anticholinergic burden and associated mortality among US older adults: a population-based study

Kai Wei iD, Shuimei Sun, Chun Chen, Yanping Yang, Dongmei Li, Yan Liu, Cailin Tang, Wenbin Jiang, Xue Bai, Kui Hu iD, Qi Chen

Age and Ageing · 01.02.2026 · 55 (2)

DOI: 10.1093/ageing/afag049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Age and Ageing, online erschienen am 05.03.2026. Verfasst von Kai Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Cholinergic Antagonists, Mortality. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Guizhou Provincial High Level Talent Project, Science and Technology Fund Project of Guizhou Provincial Health Commission, Guizhou Provincial People's Hospital Talent Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anticholinergic burden (AB) is linked to adverse health outcomes and mortality among older adults. Yet, the national trends in AB and its long-term mortality risk are not well-defined.

Methods

We analysed data from 16 188 older adults in the National Health and Nutrition Examination Survey (NHANES) spanning 32 years. AB was assessed using the 2023 American Geriatrics Society Beers Criteria® and four validated scales (ARS, ADS, ACB and ACSBC). Age-standardised prevalence trends were examined using survey-weighted logistic regression. Mortality outcomes were ascertained through linkage to the National Death Index and analysed with Cox proportional hazards models to estimate adjusted hazard ratios (HRs).

Results

From 1988–94 to 2017–March 2020, the prevalence of any strong anticholinergic medication use and high AB (score ≥ 3) declined significantly across all scales (all PTrend < .05). During a median follow-up of 81 months, 9006 deaths (49.3%) occurred. After comprehensive adjustment for covariates, high AB was independently associated with elevated all-cause mortality (ADS: HRs 1.65, 95% CI 1.51–1.81; ACB: HRs 1.54, 95% CI 1.41–1.68), cardiovascular mortality (ADS: HRs 1.94, 95% CI 1.71–2.20; ACB: HRs 1.66, 95% CI 1.46–1.88) and cancer mortality (ADS: HRs 1.40, 95% CI 1.18–1.68; ACB: HRs 1.31, 95% CI 1.09–1.57).

Conclusions

While the prevalence of AB among US older adults has declined over the past three decades, high exposure remains a strong, independent predictor of all-cause, cardiovascular and cancer mortality. These findings highlight the ongoing need for safer prescribing and sustained deprescribing initiatives in geriatric care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinergic AntagonistsMortalityHumansAgedFemaleUnited StatesMaleAged, 80 and overNutrition SurveysPrevalenceRisk FactorsCause of Death

Stichwörter der Autor:innen

anticholinergic burdenmortalityolder adultsprevalence

Substanzen

Cholinergic Antagonists

Autor:innen und Institutionen

  • Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
  • Department of Pharmacy, Guizhou Branch of Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine, Guiyang, Guizhou, China.
  • Department of Clinical Laboratory, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
  • Department of Cardiovascular Surgery, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.

ORCID-Profile: Kai Wei, Kui Hu

Förderung

  • Guizhou Provincial High Level Talent Project
  • Science and Technology Fund Project of Guizhou Provincial Health Commission
  • Guizhou Provincial People's Hospital Talent Fund
  • Guizhou Provincial Science and Technology Program
  • Guizhou Provincial People’s Hospital Talent Fund

Zitieren

APA

Wei, K., Sun, S., Chen, C., Yang, Y., Li, D., Liu, Y., Tang, C., Jiang, W., Bai, X., Hu, K., & Chen, Q. (2026). Thirty-two-year trends in anticholinergic burden and associated mortality among US older adults: a population-based study. Age and Ageing, 55(2). https://doi.org/10.1093/ageing/afag049

Vancouver

Wei K, Sun S, Chen C, Yang Y, Li D, Liu Y, et al. Thirty-two-year trends in anticholinergic burden and associated mortality among US older adults: a population-based study. Age and Ageing. 2026;55(2). doi:10.1093/ageing/afag049

BibTeX
@article{Wei2026,
  author = {Wei, Kai and Sun, Shuimei and Chen, Chun and Yang, Yanping and Li, Dongmei and Liu, Yan and Tang, Cailin and Jiang, Wenbin and Bai, Xue and Hu, Kui and Chen, Qi},
  title = {Thirty-two-year trends in anticholinergic burden and associated mortality among US older adults: a population-based study},
  journal = {Age and Ageing},
  year = {2026},
  volume = {55},
  number = {2},
  doi = {10.1093/ageing/afag049}
}
Kostenlos starten →